Reducing unnecessary high-dose heartburn medication in adults
Part of Digestive system clinical trials.
This study tests whether it is safe and helpful to reduce or stop daily high-dose heartburn medications (called PPIs) in patients who might not need them anymore. It is for adults who take a strong PPI every day and can communicate in German.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You take a proton pump inhibitor (PPI) daily for 8 weeks or more
- You take a high dose of a PPI (for example, at least 40 mg of pantoprazole or omeprazole daily)
- You understand and speak German well enough to follow the study
- You do not have a clear medical reason for long-term PPI use (like a bleeding ulcer or severe acid reflux), and you are not at high risk for stomach bleeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether educating doctors can reduce unnecessary prescriptions of proton pump inhibitors (PPIs, a type of acid-reducing medicine). If you are an adult patient who has been prescribed a PPI that might not be needed, your doctor may join this study to improve your care.
This trial studies whether a program of feedback to doctors can help reduce the use of certain medicines that may not be needed in older adults, such as benzodiazepines, acid reflux drugs, and opioids. It aims to support safe medication reduction for patients 65 and older.
This study will track how well the RefluxStop device works and its safety for treating acid reflux in a general hospital setting. It aims to help people with long-term GERD who have not found relief from other treatments.
This study tests whether it is safe to stop taking acid-reducing pills (PPIs) for people with inactive IBD. If you have been on a PPI for over 6 months and your IBD is stable, you may be able to join.
This study tests a new acid-reducing medicine (a potassium-competitive acid blocker) for people with Barrett's esophagus, a condition linked to acid reflux. It aims to see if this new treatment is safe and effective compared to standard proton pump inhibitors, and it might offer a better option for managing the condition.
This study checks whether a special test of the esophagus after meals can find the exact reason for ongoing reflux symptoms when proton pump pills (PPIs) don’t help. It may help doctors choose the right next treatment for people whose reflux symptoms keep coming back.
Hear when a new Inappropriate Prescribing trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.